Murphy & Mullick Capital Management’s Labcorp LH Stock Holding History

Murphy & Mullick Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.87K	Buy	+7	New	+$1.9K	﹤0.01%	607

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Murphy & Mullick Capital Management's LH Position: Q1 2026 in Review

Murphy & Mullick Capital Management opened a new position in Labcorp (LH) in Q1 2026: 7 shares worth $1.87K. The stake represents ﹤0.01% of the portfolio and ranks #607 among its holdings.

1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Murphy & Mullick Capital Management held 7 shares of Labcorp worth $1.87K as of Q1 2026.
Labcorp was a new Murphy & Mullick Capital Management position in Q1 2026.
Labcorp made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #607 holding.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.